Drug Master Files, manufacturer listings, and Electronic Common Technical Document (eCTD) submissions are foundational to regulatory compliance. Yet even experienced regulatory, quality, and operations...
The global Unique Device Identification (UDI) landscape is entering a critical enforcement phase — and 2026 will be a challenging year for medical device manufacturers operating in the European Union...
The FDA’s final rule, “Revising the National Drug Code Format and Drug Label Barcode Requirements,” establishes a uniform 12-digit format for FDA-assigned National Drug Codes (NDCs) ...
UDI product data is now due for specific scenarios (enforced as of December 8, 2022). Class I and Unclassified medical devices that are required to be labeled with a UDI code must submit product data...
LexisNexis Life Sciences Solutions and ONIX expand strategic alliance to guide pharma customers to market faster Professionals in the life sciences industry rely on unique regulatory affairs expertise...
LexisNexis Life Sciences how-to guides for eDRL are designed to help you understand and meet the FDA’s requirements for electronic drug registration and listing with step by step instructions and ways to simplify and expedite the process. Choose which guide fits your organization’s needs: Contract Manufacturer, OTC Drug Distributor, or Prescription Drug Distributor.
The eDRL How-to Guide answers questions like:
If you have questions about Drug Listings for OTC, prescription or other scenarios, LexisNexis Life Sciences is here to help.
Download the guide
Contents
3………Introduction 4………About FDA’s Electronic Drug Registration and Listing (eDRL) 5………Manufacturers’ Listings and Distributor’s Listings 6………Who is responsible to list a drug product 7………NDC Directory and DailyMed Publication 8………Manufacturer’s Listings Enforcement and Import Issues 9………Drug Listing and National Drug Codes (NDCs) 10……Prerequisites for drug listing submission 11……Elements of a drug listing submission 14……Conversion, submission and maintenance 15……Next Steps
3……Introduction 4……About FDA’s Electronic Drug Registration and Listing (eDRL) 5……Who is responsible to list a drug product 6……Drug Listing and National Drug Codes (NDCs) 7……Prerequisites for drug listing submission 8……Elements of a drug listing submission 11…Conversion, submission and maintenance 12…Next Steps
Contact us